AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. Tax season is a stressful time of year for us all. Just as ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. Jackson Hewitt is one of the biggest providers of in-person ...